NAMSVSSGRX• 28 Days (Normalized)
NAMS vs SGRX (NewAmsterdam Pharma Company N.V. vs SANGRIX INC.)
Showing Closing Date Range from Aug, 14 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
NAMS Performance $22.8
-15.49%
NewAmsterdam Pharma Company N.V.
Normalized Baseline0.00%
SGRX Performance $1.68
-59.02%
SANGRIX INC.
Normalized Baseline0.00%
Alpha Spread Margin NAMS LEADS
+43.53%
NAMS outperforming by 43.53%
NAMSSGRX
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
NAMS SGRX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | NAMS Price | NAMS Gain (%) | SGRX Price | SGRX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $22.80 | -15.49% | $1.68 | -59.02% | +43.53% |
| Sep 10, 2026 | $21.86 | -18.98% | $1.43 | -65.12% | +46.14% |
| Sep 09, 2026 | $22.79 | -15.53% | $1.66 | -59.51% | +43.98% |
| Sep 08, 2026 | $25.63 | -5.00% | $1.64 | -60.00% | +55.00% |
| Sep 04, 2026 | $25.40 | -5.86% | $2.10 | -48.78% | +42.92% |
| Sep 03, 2026 | $25.85 | -4.19% | $2.21 | -46.10% | +41.91% |
| Sep 02, 2026 | $25.59 | -5.15% | $2.32 | -43.41% | +38.26% |
| Sep 01, 2026 | $24.92 | -7.64% | $2.58 | -37.07% | +29.43% |
| Aug 31, 2026 | $25.34 | -6.08% | $2.77 | -32.44% | +26.36% |
| Aug 28, 2026 | $25.90 | -4.00% | $3.10 | -24.39% | +20.39% |
| Aug 27, 2026 | $26.79 | -0.70% | $3.55 | -13.41% | +12.71% |
| Aug 26, 2026 | $27.40 | +1.56% | $3.42 | -16.59% | +18.15% |
| Aug 25, 2026 | $27.34 | +1.33% | $3.62 | -11.71% | +13.04% |
| Aug 24, 2026 | $26.85 | -0.48% | $3.32 | -19.02% | +18.54% |
| Aug 21, 2026 | $27.87 | +3.30% | $3.73 | -9.02% | +12.32% |
Page 1 of 2